Skip to content Skip to navigation

Santarus Merger Review: Is $32.00 a Fair Price?

Santarus Merger Review:  Is $32.00 a Fair Price?

Santarus (SNTS) and Salix  announced that the two companies have entered into a definitive merger agreement whereby Santarus will be acquired by Salix.  The transaction, including debt, values Santarus at approximately $2.6 billion.  Under the terms of the proposal, public shareholders of Santarus will receive $32.00 in cash for each share of SNTS common stock they own. 

Salix’s takeover of Santarus raises an obvious question:  Is this the best the Santarus board could do?

If you own the common stock of Santarus and are concerned about the transaction and would like to learn more about how to begin a cost-free corporate review of this merger, please fill out the contact form on this web page or call Attorney George Pressly at 1-(800)-631-6234.

Santarus’ board of directors owe Santarus shareholders specific duties when selling the company

  1. Is $32.00 per share a fair price for Santarus shareholders? 
  2. Does the Santarus merger agreement contain an unfair termination provision?  
  3. Does the merger agreement limit the ability of Santarus to obtain additional suitors or to accept additional proposals?  
  4. Did the Santarus board of directors obtain a fairness opinion from an independent investment bank?
  5. What did the independent fairness show?  
  6. Did the board of directors engage other potential suitors?
  7. Will there be full disclosure regarding future executive compensation packages?

Santarus merger or takeover shareholder lawsuit investigation

State security laws provide shareholders a no cost means to question a proposed sale of a publicly traded company.  This review process is deemed a shareholder class action and affords at times shareholders an avenue to investigate fully the proposed transaction.  At minimum, this process often obtains answers to the above questions.  If you own the common stock of Santarus and if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please fill out the contact form on this web page.

Topic: